DEA Schedule CV
Strength
150 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598029590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA209664On Market Since
7/19/2019
Related Drugs
Same classification
No related drugs found.